Hepatitis Research Today is a free monthly online journal that collates and summarizes the latest research about Hepatitis, including details on hepatitis a, b, c, causes, symptoms.

Volume 3 (2008), Issue 1 (January)

1. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
   Autoimmunity, 41(1): 105-10. [Abstract] [Full-text]
2. Serum autoantibodies: a road map for the clinical hepatologist.
   Autoimmunity, 41(1): 27-34. [Abstract] [Full-text]
3. Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient.
   South Med J, 101(1): 88-90. [Abstract] [Full-text]
4. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
   J Clin Oncol, 26(2): 177-82. [Abstract] [Full-text]
5. Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
   Clin Infect Dis, 46(3): e28-30. [Abstract] [Full-text]
6. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children.
   Clin Infect Dis, 46(3): 361-6. [Abstract] [Full-text]
7. Hepatitis B virus transmission in The Netherlands: a population-based, hierarchical case-control study in a very low-incidence country.
   Epidemiol Infect, 136(2): 184-95. [Abstract] [Full-text]
8. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients.
   Expert Opin Biol Ther, 8(2): 235-47. [Abstract] [Full-text]
9. A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patients.
   J Infect Dis, 197(2): 292-4. [Abstract] [Full-text]
10. Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.
    J Infect Dis, 197(2): 283-91. [Abstract] [Full-text]
11. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia.
    Pediatr Blood Cancer, 50(3): 647-9. [Abstract] [Full-text]
12. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis.
    J Virol, 82(3): 1259-70. [Abstract] [Full-text]
13. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Pharmacogenomics J, 8(1): 61-70. [Abstract] [Full-text]
14. Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study.
    Pharmacogenomics J, 8(1): 29-33. [Abstract] [Full-text]
15. Low frequency of Helicobacter DNA in benign and malignant liver tissues from Baltimore, United States.
    Hum Pathol, 39(2): 213-6. [Abstract] [Full-text]
16. Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma.
    Hum Pathol, 39(2): 209-12. [Abstract] [Full-text]
17. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia.
    Sex Transm Infect, 84(1): 37-41. [Abstract] [Full-text]
18. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
    Am J Kidney Dis, 51(2): 263-77. [Abstract] [Full-text]
19. Serum proteomic-based analysis for the identification of a potential serological marker for autoimmune hepatitis.
    Biochem Biophys Res Commun, 367(2): 284-90. [Abstract] [Full-text]
20. Transmission routes of hepatitis B virus infection in chronic hepatitis B patients in The Netherlands.
    J Med Virol, 80(3): 399-404. [Abstract] [Full-text]
21. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus.
    J Med Virol, 80(3): 405-10. [Abstract] [Full-text]
22. The effect of early virological response in health-related quality of life in HCV-infected patients.
    J Med Virol, 80(3): 419-23. [Abstract] [Full-text]
23. A prospective study of change in visual function in patients treated with pegylated interferon alpha for hepatitis C in the UK.
    Br J Ophthalmol, 92(2): 256-8. [Abstract] [Full-text]
24. Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
    Aliment Pharmacol Ther, 27(5): 433-40. [Abstract] [Full-text]
25. Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.
    Aliment Pharmacol Ther, 27(5): 422-32. [Abstract] [Full-text]
26. A mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.
    Clin Exp Immunol, 151(3): 441-7. [Abstract] [Full-text]
27. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help.
    J Virol, 82(4): 1827-37. [Abstract] [Full-text]
28. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco.
    J Viral Hepat, 15(3): 229-36. [Abstract] [Full-text]
29. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    J Viral Hepat, 15(3): 200-11. [Abstract] [Full-text]
30. Genetic variability in hepatitis C virus and its role in antiviral treatment response.
    J Viral Hepat, 15(3): 188-99. [Abstract] [Full-text]
31. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
    J Viral Hepat, 15(3): 179-87. [Abstract] [Full-text]
32. Susceptibility to active decompensated cirrhosis is associated with polymorphisms of intercellular adhesion molecule-1 (ICAM-1) in chronic HBV carriers.
    J Viral Hepat, 15(3): 173-8. [Abstract] [Full-text]
33. Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus.
    J Viral Hepat, 15(3): 219-28. [Abstract] [Full-text]
34. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    J Viral Hepat, 15(3): 212-8. [Abstract] [Full-text]

© 2006-2008 Hepatitis Research Today. All Rights Reserved.